Biomerica Inc (BMRA):企業の製品パイプライン分析

【英語タイトル】Biomerica Inc (BMRA) - Product Pipeline Analysis, 2020 Update

GlobalDataが出版した調査資料(GDME1309PD)・商品コード:GDME1309PD
・発行会社(調査会社):GlobalData
・発行日:2021年1月
・ページ数:40
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose various diseases and medical complications. It focuses on the development of products for diabetes, gastrointestinal, food intolerances and esoteric tests by utilizing enzyme immunoassay technology. Biomerica’s diagnostic tests are used by hospitals, clinical laboratories, physician’s offices, and consumers around the world. The company distributes products in Americas, Europe, Asia and the Middle East. Biomerica is headquartered in Irvin, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biomerica Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Biomerica Inc Company Overview
Biomerica Inc Company Snapshot
Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
Biomerica Inc – Pipeline Analysis Overview
Business Description
Biomerica Inc – Key Facts
Biomerica Inc – Major Products and Services
Biomerica Inc Pipeline Products by Development Stage
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc Pipeline Products Overview
HP Detect H. Pylori Test
HP Detect H. Pylori Test Product Overview
InFoods – Crohn’s Disease
InFoods – Crohn’s Disease Product Overview
InFoods – Functional Dyspepsia
InFoods – Functional Dyspepsia Product Overview
InFoods – Gastroesophageal Reflux Disease
InFoods – Gastroesophageal Reflux Disease Product Overview
InFoods – Ulcerative Colitis
InFoods – Ulcerative Colitis Product Overview
InFoods IBS
InFoods IBS Product Overview
InFoods IBS Clinical Trial
Rapid IgG/IgM Test – COVID-19
Rapid IgG/IgM Test – COVID-19 Product Overview
Serological ELISA Test – COVID-19
Serological ELISA Test – COVID-19 Product Overview
Biomerica Inc – Key Competitors
Biomerica Inc – Key Employees
Biomerica Inc – Key Employee Biographies
Biomerica Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biomerica Inc, Recent Developments
Jan 07, 2020: Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods irritable bowel syndrome (IBS) diagnostic guided therapy clinical trial
Oct 16, 2019: Biomerica reports 1st quarter fiscal 2020 financials
Aug 30, 2019: Biomerica announces fiscal year end 2019 financial results
Aug 21, 2019: Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
Jun 05, 2019: Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million
Apr 16, 2019: Biomerica announces third quarter financial results
Apr 08, 2019: Biomerica announces Notice of Allowance for new U.S. Patent application covering diagnostic guided therapy for irritable bowel syndrome (IBS)
Feb 05, 2019: Biomerica announces updates for H. Pylori clinical studies
Jan 15, 2019: Biomerica announces second quarter financial results
Oct 16, 2018: Biomerica announces 1st Quarter Fiscal 2019 Financials
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
Biomerica Inc Pipeline Products by Equipment Type
Biomerica Inc Pipeline Products by Indication
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc, Key Facts
Biomerica Inc, Major Products and Services
Biomerica Inc Number of Pipeline Products by Development Stage
Biomerica Inc Pipeline Products Summary by Development Stage
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc Ongoing Clinical Trials Summary
HP Detect H. Pylori Test - Product Status
HP Detect H. Pylori Test - Product Description
InFoods - Crohn’s Disease - Product Status
InFoods - Crohn’s Disease - Product Description
InFoods - Functional Dyspepsia - Product Status
InFoods - Functional Dyspepsia - Product Description
InFoods - Gastroesophageal Reflux Disease - Product Status
InFoods - Gastroesophageal Reflux Disease - Product Description
InFoods - Ulcerative Colitis - Product Status
InFoods - Ulcerative Colitis - Product Description
InFoods IBS - Product Status
InFoods IBS - Product Description
InFoods IBS - Endpoint Determination Study for an Antibody Guided Dietary Restriction Trial Using Biomerica InFoods IBS Test in Patients with a Previous Diagnosis of Irritable Bowel Syndrome (IBS)
Rapid IgG/IgM Test - COVID-19 - Product Status
Rapid IgG/IgM Test - COVID-19 - Product Description
Serological ELISA Test - COVID-19 - Product Status
Serological ELISA Test - COVID-19 - Product Description
Biomerica Inc, Key Employees
Biomerica Inc, Key Employee Biographies
Biomerica Inc, Subsidiaries
Glossary

★調査レポート[Biomerica Inc (BMRA):企業の製品パイプライン分析] (コード:GDME1309PD)販売に関する免責事項を必ずご確認ください。
★調査レポート[Biomerica Inc (BMRA):企業の製品パイプライン分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆